Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

RLS Global

1997 FOUNDED
PUBLIC STATUS
1-10 EMPLOYEES
RLS STOCK SYMBOL
$0.60 SHARE PRICE (As of Monday Closing)
Description

RLS Global AB develops and sells biochemical products for the treatment of some of common diseases in wound and dental care.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
STO
Primary Office
  • Medicinaregatan 8B
  • 413 46 Goteborg
  • Sweden

+46 031-780 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore RLS Global’s full profile, request a free trial.

RLS Global Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.53 - $1.16 $35.2M $0.55 -$0.04 23.6K 59.2M

RLS Global Financials Summary

In Thousands,
USD
TTM
30-Sep-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 53,892 35,804 59,558 35,261
Revenue 234 273 336 250
EBITDA (2,542) (2,188) (1,535) (1,013)
Net Income (2,612) (2,262) (1,606) (1,052)
Total Assets 4,948 7,233 1,363 1,122
Total Debt 0 549 357
Public Fundamental Data provided by Morningstar, Inc. disclaimer